Close Menu

NEW YORK (360Dx) – Qiagen and DiaSorin said today that they are working together to develop an ultra-sensitive in vitro diagnostic test for Lyme disease that combines Qiagen's QuantiFeron (interferon-gamma release assay) technology with DiaSorin's Liaison automated analyzers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.